Skip to main content

Table 3 Characteristics of patients who died

From: Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis

Characteristics

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Patient 7

Age at diagnosis

40–50

50–60

30–40

70–80

70–80

70–80

50–60

Body mass index

20.7

27.0

22.8

27.0

31.4

29.0

25.0

Family history

No

No

Yes

No

Yes

No

No

Smoke

No

No

No

Yes

No

No

No

Alcohol intake

No

Yes

No

No

Yes

No

No

Obesity

No

No

No

No

Yes

No

No

Side

Left

Left

Right

Left

Left

Right

Left

Stage

IV

II

II

III

I

III

Unknown

Histotype

Ductal

Ductal

Ductal

Ductal

Ductal

Ductal

Ductal

HR status

ER+

ER-/PgR-

ER+/PgR+

ER+/PgR+

ER+/PgR+

ER+/PgR+

Unknown

HER-2 positive

Yes

Unknown

No

Yes

No

No

Unknown

Ki-67 high-level (cutoff 20 %)

Unknown

Unknown

No

Yes

Yes

Yes

Unknown

Surgery

M

M

M

Q

M

M

M

Radiotherapy

Yes

No

No

Yes

No

No

No

Chemotherapy

Yes

Yes

Yes

Unknown

No

Yes

No

Endocrine therapy

Yes

No

Yes

Unknown

Unknown

Yes

No

Trastuzumab

Yes

No

No

Unknown

No

No

No

Relapse

Yes

No

Yes

Yes

No

Unknown

Yes

Other tumors

Yes

No

Yes

Yes

No

No

Yes

BRCA mutation

No test

No test

BRCA 1

BRCA 2

BRCA 2

No test

No test

Follow-up (days)

2465

5706

1795

1096

1031

173

3713

  1. For single patients, age is reported as decade range to maintain participant confidentiality
  2. Abbreviations: ER estrogen receptor, HR hormone receptor, M mastectomy, PgR progesterone receptor, Q quadrantectomy